Demodex mite infestation in patients with and without rheumatoid arthritis

• Autorzy: Garbacewicz A. , Jaworski J. , Grytner-Ziecina B.
• Języki publikacji: EN

Abstrakty

EN

In the present study we compared the prevalence of Demodex mites in patients with rheumatoid arthritis and in one control group involving individuals of similar mean age. From each person we epilated 3–4 lashes from each eyelid and examined them under a microscope to find Demodex mites. In total 147 patients were examined. The prevalence of Demodex mites was 33% in rheumatoid arthritis (RA) patients and 31% in the control group. Our results demonstrated that the prevalence of Demodex mites was similar in RA patients as compared to the control group.

Słowa kluczowe

EN

Demodex; mite; infestation; patient; rheumatoid arthritis; Demodex folliculorum; Demodex brevis; parasite; arthropathy; autoimmune disease; inflammatory disease

• Wydawca: -
• Czasopismo: Acta Parasitologica
• Rocznik: 2012
• Tom: 57
• Numer: 1
• Opis fizyczny: p.99-100,ref.

Twórcy

autor

Garbacewicz A.

• Department of General Biology and Parasitology, Medical University of Warsaw, 5 Chałubinskiego Street, 02-004 Warsaw, Poland

autor

Jaworski J.

autor

Grytner-Ziecina B.

Bibliografia

• Ashack R.J., Frost M.L., Norins A.L. 1989. Papular pruritic eruption of Demodex folliculitis in patients with acquired immunodeficiency syndrome. Journal of the American Academy of Dermatology, 21, 306–307. DOI: 10.1016/S0190-9622(89)70182-1.
• Bonnar E., Eustace P., Powell F.C. 1993. The Demodex mite population in rosacea. Journal of the American Academy of Dermatology, 28, 443–448. DOI: 10.1016/01909622(93)70065-2.
• Bovenschen H.J., Tjioe M., Vermaat H., de Hoop D., Witteman B.M., Janssens R.W., Stoof T.J., Kerkhof P.C. 2006. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. British Journal of Dermatology, 154, 880–884. DOI: 10.1111/j.1365-2133.2006.07189.x.
• Czepita D., Kuźna-Grygiel W., Kosik-Bogacka D. 2005. Investigations on the occurrence as well as the role of Demodex folliculorum and Demodex brevis in the pathogenesis of blepharitis. Klinika Oczna, 107, 80–82.
• Damian D., Rogers M. 2003. Demodex infestation in a child with leukaemia: treatment with ivermectin and permethrin. International Journal of Dermatology, 42, 724–726. DOI: 10.1046/j.1365-4362.2003.01916.x.
• Desch C., Nutting W.B. 1972. Demodex folliculorum (Simons) and D. brevis Akbulatova of man: redescription and reevaluation. Journal of Parasitology, 8, 169–177. DOI:10.2307/3278267.
• Garbacewicz A., Twarowska J., Grytner-Zięcina B. 2010. Demodex infection in different groups in the population of Warsaw. In: (Eds. A. Buczek and C. Błaszak) Arthropods. Ecological and pathological aspects of parasite — host relationships. Akapit, Lublin, 57–64.
• Herron M.D., O’Reilly M.A., Vanderhooft S.L. 2005. Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia. Pediatric Dermatology, 22, 407–411. DOI: 10.1111/j.1525-1470.2005.00103.x.
• Humiczewska M., Kuźna W., Hermach U. 1994. Frequency of occurrence of symptomatic and asymptomatic eyelids demodecosis among the inhabitants of Szczecin. Wiadomości Parazytologiczne, 40, 69–71.
• Ciftci I.H., Dundar U., Cetinkaya Z., Kulac M., Kiyildi N., Turel A., Evcik D., Kavuncu V. 2007. Demodex folliculorum in patients with rheumatoid arthritis. Acta Parasitologica, 52, 70–73. DOI: 10.2478/s11686-007-0002-7.
• Ivy S.P., Mackall C.L., Gore L., Gress R.E., Hartley A.H. 1995. Demodicidosis in childhood acute lymphoblastic leukaemia: an opportunistic infection occurring with immunosuppression. Journal of Pediatrics, 127, 751–754. DOI: 10.1016/S0022-3476(95)70168-0.
• Jansen T., Kastner U., Kreuter A., Altmeyer P. 2001. Rosacea-like demodicidosis associated with acquired immunodeficiency syndrome. British Journal of Dermatology, 144, 139–142. DOI: 10.1046/j.1365-2133.2001.03794.x.
• Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., Smolen J.S., Weisman M., Emery P., Feldmann M., Harrman G.R., Maini R.N. 2000. Infliximab and Methotrexate in the treatment of Rheumatoid Arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. New England Journal of Medicine, 343, 1594–1602. DOI: 10.1056/nejm2000113034 32202.